These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10709681)

  • 21. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines.
    Liu Q; Chan ST; Mahendran R
    Carcinogenesis; 2003 Apr; 24(4):637-42. PubMed ID: 12727790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
    Feldman M; McMahon AT
    Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275
    [No Abstract]   [Full Text] [Related]  

  • 24. [COX-1 and COX-2: functions and pharmacological effects].
    Hinz B; Brune K
    Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M; Olczak S
    Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin and salicylate: An old remedy with a new twist.
    Wu KK
    Circulation; 2000 Oct; 102(17):2022-3. PubMed ID: 11044413
    [No Abstract]   [Full Text] [Related]  

  • 27. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
    Tishler M; Langevetiz P; Nesher G
    Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
    Elder DJ; Halton DE; Hague A; Paraskeva C
    Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 31. The molecular perspective: cyclooxygenase-2.
    Goodsell DS
    Oncologist; 2000; 5(2):169-71. PubMed ID: 10794808
    [No Abstract]   [Full Text] [Related]  

  • 32. Nonsteroidal anti-inflammatory drugs and Alzheimer disease: what's next?
    Launer LJ
    JAMA; 2003 Jun; 289(21):2865-7. PubMed ID: 12783919
    [No Abstract]   [Full Text] [Related]  

  • 33. [Colon cancer and COX-2].
    Ota S; Bamba H; Imai Y; Arai S; Fujiwara K
    Nihon Shokakibyo Gakkai Zasshi; 2002 Mar; 99(3):253-63. PubMed ID: 11925862
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.
    Tsujii M; Kawano S; DuBois RN
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3336-40. PubMed ID: 9096394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [COX-2 inhibition: latest on NSAID].
    Z Orthop Ihre Grenzgeb; 1997; 135(1):Oa20-1. PubMed ID: 9199064
    [No Abstract]   [Full Text] [Related]  

  • 36. Heterogeneous distribution of COX-2 over-expression in human colon carcinoma cells.
    Berg J; Christoph T; Bodenteich A; Towart R
    Adv Exp Med Biol; 1997; 433():327-30. PubMed ID: 9561163
    [No Abstract]   [Full Text] [Related]  

  • 37. [A heterogenous drug class. NSAID: classification and spectrum of action].
    Ulbrich H; Dannhardt G
    Pharm Unserer Zeit; 2002; 31(2):146-54. PubMed ID: 11977450
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular perspective: cyclooxygenase-2.
    Goodsell DS
    Stem Cells; 2000; 18(3):227-9. PubMed ID: 10840077
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclooxygenase-independent induction of p21WAF-1/CIP1, apoptosis and differentiation by L-745,337 and salicylate in HT-29 colon cancer cells.
    Patrignani P; Santini G; Sciulli MG; Marinacci R; Fusco O; Spoletini L; Natoli C; Procopio A; Maclouf J
    Adv Exp Med Biol; 1999; 469():555-61. PubMed ID: 10667382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.